RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Md Nurunnabi to Melanoma

Back to Details
This is a "connection" page, showing publications Md Nurunnabi has written about Melanoma.
Md Nurunnabi
Connection Strength
1.607
Melanoma
  1. Bhatt HN, Diwan R, Borrego EA, P?rez CAM, Varela-Ramirez A, Kumar R, Aguilera RJ, Nurunnabi M. A photothermal driven chemotherapy for the treatment of metastatic melanoma. J Control Release. 2023 09; 361:314-333.
    View in: PubMed
    Score: 0.832
  2. Huda MN, Deaguero IG, Borrego EA, Kumar R, Islam T, Afrin H, Varela-Ramirez A, Aguilera RJ, Tanner EEL, Nurunnabi M. Ionic liquid-mediated delivery of a BCL-2 inhibitor for topical treatment of skin melanoma. J Control Release. 2022 09; 349:783-795.
    View in: PubMed
    Score: 0.775
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support